Cellectar Biosciences Inc (CLRB)
3.30
-0.03
(-0.90%)
USD |
NASDAQ |
May 17, 16:00
3.295
0.00 (0.00%)
Pre-Market: 20:00
Cellectar Biosciences Cash from Investing (Quarterly): -0.0216M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.0216M |
| December 31, 2023 | -0.2668M |
| September 30, 2023 | -0.5973M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | -0.1179M |
| September 30, 2022 | -0.0071M |
| June 30, 2022 | -0.071M |
| March 31, 2022 | -0.0301M |
| December 31, 2021 | -0.1297M |
| September 30, 2021 | -0.0041M |
| June 30, 2021 | -0.0076M |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.0172M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | -0.0346M |
| March 31, 2020 | -0.0106M |
| December 31, 2019 | -0.0057M |
| September 30, 2019 | -0.0031M |
| June 30, 2019 | -0.0095M |
| March 31, 2019 | -0.0062M |
| December 31, 2018 | -0.3736M |
| September 30, 2018 | 0.045M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.0014M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.00 |
| September 30, 2017 | -0.0262M |
| June 30, 2017 | -0.2542M |
| March 31, 2017 | -0.0663M |
| December 31, 2016 | -0.067M |
| September 30, 2016 | -0.0011M |
| June 30, 2016 | -0.0042M |
| March 31, 2016 | 0.00 |
| December 31, 2015 | -0.0187M |
| September 30, 2015 | -0.0061M |
| June 30, 2015 | -0.0082M |
| March 31, 2015 | -0.0255M |
| December 31, 2014 | -0.0122M |
| September 30, 2014 | -0.0022M |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.0152M |
| December 31, 2013 | -0.0129M |
| September 30, 2013 | 1.836M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.0288M |
| December 31, 2012 | -2.060M |
| September 30, 2012 | -0.008M |
| June 30, 2012 | -0.014M |
| March 31, 2012 | -0.0151M |
| December 31, 2011 | -0.0062M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.5973M
Minimum
Sep 2023
--
Maximum
Sep 2020
-0.0667M
Average
-0.01M
Median
Cash from Investing (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -47.30M |
| Eli Lilly and Co | -1.178B |
| Actinium Pharmaceuticals Inc | -0.011M |
| Bristol-Myers Squibb Co | -19.62B |
| Altimmune Inc | -39.52M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.36M |
| Cash from Financing (Quarterly) | 43.85M |
| Free Cash Flow | -39.44M |
| Free Cash Flow Per Share (Quarterly) | -0.456 |
| Free Cash Flow Yield | -71.38% |